Oncimmune Germany GmbH.

General information
Oncimmune Germany GmbH.
Otto-Hahn-Straße 15
44227 Dortmund, North Rhine-Westphalia

Contact person: Rita Monaghan, Chief Financial Officer
Company main phone: +49 (231) 97426300
Company main fax:  +49 (231) 97426301
Website:  https://oncimmune.com
Source of foundation:Subsidiary
Name of foundation source:Oncimmune Holdings plc
Corporate description / mission:
Oncimmune is dedicated to the development of precision diagnostic tools that aid therapeutic development and facilitate improved treatment strategies in the areas of immuno-oncology and autoimmune disease. The company focuses on the assay development programs on disease-specific autoantibodies.
State of ownership: Subsidiary
Headquarters: HQ: No
Remarks on ownership / listings
Previously known as Protagen AG; acquired by Oncimmune in 2019.
  • Biotechnology - R&D Services
  • Diagnostic instrumentation
Business model:
  • R&D
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Summary Products / Services / Technologies
Description of products:
EarlyCDT® Lung is an extensively validated test for the levels of seven autoantibodies to tumour-associated antigens.
Technology used:
SeroTag Platform